Mercer Global Advisors »

BioCryst Pharmaceuticals shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $615k 62k 10.00
2026-03-31 $95k 10k 9.52
2025-09-30 $81k 11k 7.59

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
TCG Crossover Management
Perceptive Advisors
Jupiter Topco
Henderson Group
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Standard Life Aberdeen
UBS Group

View all funds holding BioCryst Pharmaceuticals